Choosing an EDC vendor requires more than comparing feature lists. Sponsors should also consider compliance, usability, implementation fit, support, scalability, and how well the system will work in real study operations.
Ophthalmology studies can involve imaging, specialized assessments, and data collected across multiple settings. Well-designed EDC workflows help keep that information consistent, traceable, and ready for review.
Global studies add layers of operational, security, and governance complexity. Enlighten continues to expand its platform capabilities to support clinical research across regions while maintaining controlled, consistent workflows.
Cloud-based EDC can give ophthalmology teams faster access to study data while supporting consistency, traceability, and regulatory requirements. The value comes from workflows designed around the realities of ophthalmic research.
EDC is evolving alongside automation, AI, decentralized research, and growing expectations for real-time visibility. This roadmap looks at the capabilities clinical teams should be preparing for next.
Sponsor oversight depends on seeing more than isolated data points. Better visibility helps teams understand study progress, identify emerging issues, and make informed decisions without relying on disconnected reports.
Accurate clinical data starts with how information is captured, validated, reviewed, and corrected. Modern EDC systems can build those controls into the workflow rather than relying on cleanup later.
A foundational overview of EDC regulatory compliance, explaining FDA expectations, system validation, and inspection readiness for clinical trial sponsors and CROs.
Describes what clinical teams should expect when transitioning from paper-based processes to EDC, including operational changes, training needs, and workflow impacts.
Examines how artificial intelligence is being applied within EDC systems to support data review, risk identification, and operational efficiency in clinical trials.
